Company news
Syntara Limited (ASX:SNT) news
Syntara Limited news releases on 6ix. Latest, Jan 11, 2018: Pharmaxis Earns A$15 Million Milestone Payment
Press releases — page 3
Pharmaxis Earns A$15 Million Milestone Payment
January 10, 2018
New Australian PBS Listing for Brocnhitol
January 1, 2018
Pharmaxis Acquires Control, Increases Stake in LOXL2 Program
December 13, 2017
Boehringer Initiating Phase 2a Study Diabetic Retinopathy
September 7, 2017
Antifibrotic LOXL2 Program Clears Preclinical Development
September 5, 2017
Boehringer Ingelheim Initiates Phase IIa Study in NASH
August 24, 2017
Positive Recommendation for Broader Bronchitol Access in Aus
August 18, 2017
Preliminary Final Report June 2017
August 10, 2017
Appendix 4C - quarterly June 2017
July 28, 2017
Pharmaxis Announces Results of Pivotal CF Clinical Trial
June 12, 2017
Pharmaxis Set to Generate Further Euro 10m Milestone Payment
May 14, 2017
Pharmaxis Appoints Chiesi as Bronchitol Distributor in Italy
May 8, 2017
Appendix 4C - quarterly cash flow
April 18, 2017
Quarterly Shareholder Update March 2017
April 17, 2017
Synairgen Collaboration Progress
March 12, 2017
Chairmans Address to Shareholders
November 29, 2016
Research Collaboration with Woolcock Institute
November 15, 2016
S&P DJ Indicies Announces March Quarterly Rebalance
November 7, 2016
Pharmaxis Announces Russian Approval for Bronchitol
September 26, 2016
Pharmaxis Completes Recruitment of CF Clinical Trial for US
July 14, 2016
Appendix 4C - quarterly March 2016
April 14, 2016
US FDA Accepts Bronchitol New Drug Application for Review
March 30, 2016
Quarterly Share Update - December 2015
February 11, 2016
Bronchitol Paediatric CF Trial Reports Postive Results
February 10, 2016